Market Place
Sourcing Support
Ixaka Expands IP Portfolio to Enable Use of Nanoparticle in vivo Gene Delivery
21 Mar 2022 //
BUSINESSWIRE
Cell door: EMA grants ATMP classification to CELTIC-19
08 Mar 2022 //
PHARMATIMES
CELTIC-19 Granted ATMP Classification by European Medicines Agency
07 Mar 2022 //
BUSINESSWIRE
Ixaka Expands Management Team with Multiple Appointments
10 Feb 2022 //
BUSINESSWIRE
Ixaka announces positive interim Ph3 clinical trial data for REX-001
08 Sep 2021 //
BUSINESSWIRE
Positive interim data for Ixaka’s lead ‘multi-cell’ therapy
08 Sep 2021 //
PHARMA TIMES
Ixaka to present in vivo gene delivery platform for CAR-T at CAR TCR Summit
31 Aug 2021 //
BUSINESSWIRE
Ixaka Appoints Laurent Audoly as a Non-Executive Director
02 Aug 2021 //
BUSINESS WIRE
Ixaka and SomaLogic Enter Research Collaboration
29 Jun 2021 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.